Ranked among the Top 100 Companies
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today announced its participation at the Jefferies Global Healthcare...
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today reported the following third quarter results for the period ended...
Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S Food and Drug Administration (FDA) has granted 510(k) clearance for HeroTracker ...
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named a World’s Top Companies for Women...
In a report released today, Gabrial Hajde from Wells Fargo maintained a Buy rating on AptarGroup, with a price target of $152.00. The company’s shares closed yesterday at $133.18.Elevate Your Investing...
Following an increase of almost 10% a year ago
AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, will host an Investor Day on Tuesday, September 9, 2025. The event will begin at...